Veteran investment executive with multi-decade experience across private equity, corporate finance and asset management, focused on value creation and operational improvement. Scott D. Lasky combines operating leadership, portfolio management and board service supporting growth-stage and middle-market companies across technology, healthcare and consumer sectors. Regularly engaged in deal sourcing, M&A execution, capital formation and investor relations, he is positioned as a strategic sponsor for buyouts, growth equity and turnaround situations.
Veteran investment executive with multi-decade experience across private equity, corporate finance and asset management, focused on value creation and operational improvement. Scott D. Lasky combines operating leadership, portfolio management and board service supporting growth-stage and middle-market companies across technology, healthcare and consumer sectors. Regularly engaged in deal sourcing, M&A execution, capital formation and investor relations, he is positioned as a strategic sponsor for buyouts, growth equity and turnaround situations.
Combines operational leadership and private-capital discipline to target value-accretive opportunities in growth-stage and middle-market companies. Prefers control or significant influence positions where active board engagement and hands-on operational improvement drive EBITDA expansion and strategic M&A. Uses a flexible capital approach—buyouts, growth equity and restructurings—with focus on technology, healthcare and consumer verticals. Investment horizon is medium to long-term, emphasizing rigorous due diligence, conservative leverage, staged capital deployment and exit-ready value creation plans aligned with management and limited partners.
Combines operational leadership and private-capital discipline to target value-accretive opportunities in growth-stage and middle-market companies. Prefers control or significant influence positions where active board engagement and hands-on operational improvement drive EBITDA expansion and strategic M&A. Uses a flexible capital approach—buyouts, growth equity and restructurings—with focus on technology, healthcare and consumer verticals. Investment horizon is medium to long-term, emphasizing rigorous due diligence, conservative leverage, staged capital deployment and exit-ready value creation plans aligned with management and limited partners.
| Trades 645 | Longs Won 399/645 61% | Profit Factor 5.69 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $175,861.38 |
| Average Win $76,718.79 | Best Trade (Sep 01) $1.58M | Sharpe Ratio -12.8 |
| Average Loss -$21,884.6 | Worst Trade (Mar 31) -$452,586.22 | Z-Score 1.93 (94.68%) |
| Commissions $0 | Avg. Trade Length 9m 2w 5d | Expectancy $39,111.92 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,092 | 6,383 | 5,674 | 4,965 | 4,255 | 3,546 | 2,837 | 2,128 | 1,418 | 709 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 25,169 | $6.35M | $7.77M | - | $1.43M | 22.46% | -7.354% |
ABBV AbbVie Inc. | 4,720 | $1.05M | $1.18M | - | $131,762.78 | 12.52% | -2.539% |
ABT Abbott Laboratories | 2,221 | $300,034.31 | $234,759.7 | - | -$65,274.61 | -21.76% | +0.085% |
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund | 10,753 | $467,345.76 | $458,077.8 | - | -$9,267.96 | -1.98% | -0.211% |
AMD Advanced Micro Devices, Inc. | 5,120 | $767,482.08 | $2.44M | - | $1.67M | 217.65% | -1.904% |
AMZN Amazon.com Inc | 5,951 | $1.31M | $1.62M | - | $310,564.4 | 23.79% | +15.321% |
AOS A. O. Smith Corporation | 18,976 | $1.27M | $1.14M | - | -$131,788.57 | -10.35% | +0.535% |
ASTS AST SpaceMobile, Inc. | 5,000 | $233,650 | $294,900 | - | $61,250 | 26.21% | +0.924% |
AVDS Avantis International Small Cap Equity ETF | 2,984 | $185,624.25 | $227,947.16 | - | $42,322.91 | 22.8% | -0.599% |
AVGO Broadcom Inc. | 652 | $246,293 | $253,810.56 | - | $7,517.56 | 3.05% | +0.371% |
AXP American Express Company | 606 | $204,980 | $203,767.5 | - | -$1,212.5 | -0.59% | -0.376% |
AZZ Azz Inc. | 14,000 | $1.45M | $2.03M | - | $576,730 | 39.79% | -0.166% |
B BARRICK MINING CORP Common Stock (ABR0) | 6,388 | $209,335 | $234,631.24 | - | $25,296.24 | 12.08% | -2.573% |
BA Boeing Company | 1,443 | $312,366 | $311,890.02 | - | -$475.98 | -0.15% | -2.155% |
BAB Invesco Taxable Municipal Bond ETF | 10,210 | $268,916.84 | $268,318.8 | - | -$598.04 | -0.22% | -0.341% |
BAC Bank of America Corporation | 4,821 | $249,216.54 | $298,660.95 | - | $49,444.41 | 19.84% | +0.356% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 75,759 | $5.7M | $5.72M | - | $21,478 | 0.38% | -0.198% |
BNY BlackRock New York Municipal Income Trust | 7,339 | $566,669.26 | $1.15M | - | $580,636.61 | 102.46% | +0.16% |
BOND PIMCO Active Bond Exchange-Traded Fund | 8,920 | $813,388.28 | $807,170.8 | - | -$6,217.48 | -0.76% | -0.33% |
BRK-B Berkshire Hathaway Inc. | 1,704 | $776,344.82 | $871,664.16 | - | $95,319.34 | 12.28% | +0.365% |